OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
June 08, 2012
In addition to the established coating systems (like the BFC and the BFC TriPan), Bohle developed a new coater to face the market needs, the Bohle-Tablet-Coater BTC.
June 07, 2012
Dr. Reddy's Laboratories and Merck Serono, a division of Merck KGaA, have partnered to codevelop a portfolio of biosimilar compounds in oncology.
June 02, 2012
Extensive physicochemical characterization of the innovator product and the proposed biosimilar provides the foundation for demonstrating biosimilarity.
How to avoid invisible and airborne contamination.
Partnerships between industry and academic medical centers are expanding to meet R&D needs.
New coating technologies achieve high uniformity and reduce waste through mixing system advances and pan and airflow configuration.
Does global development have to entail multiple comparability studies?
May 22, 2012
PDA Revises Technical Report on Sterilized Products
The Parenteral Drug Association has released guidance on the detection and mitigation of 2,4,6-tribromoanisole and 2,4,6-trichloroanisole taints and odors in pharmaceutical and healthcare products.
May 16, 2012
Advances in process analytical technology and in defining lots for release are key for enabling use of continuous processes in solid-dosage manufacturing.